Read the latest ideas, insights and observations on the Australian Medicinal Cannabis Industry from the team at FreshLeaf Analytics.
New Zealand draft recreational cannabis legislation released Whether you like it or not, having both medical and non-medical cannabis frameworks in place means there will
Publication: Small Caps
Publication: Stockhead
Publication: Stockhead The number of Australian patients receiving medicinal cannabis is exploding
Publication: Business Marijuana Daily
Publication: Business Marijuana Daily
As medical cannabis access gets easier, governments will miss out on public health data Recent reforms at the State level in NSW and QLD mean
New WA laws could see medicinal cannabis prices drop Publication: Small Caps
ANTG second Australian company to bring domestically cultivated products to market ANTG, a NSW-based medicinal cannabis company, has announced that their first product is
Australia launches Senate inquiry into medical cannabis patient access The Australian Senate has just launched an inquiry into patient access to medical cannabis. The matter
© 2022 All rights reserved, FreshLeaf Analytics
The H2 2021 report is FreshLeaf Analytics’ seventh market
report on patients, products and pricing in the Australian
medicinal cannabis market.
